Therapeutic vaccination for central nervous system repair

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 5-6, 2006, Pages 541-545

  Ang, Beng Ti ^a,b   Xu, Gang ^b,c   Xiao, Zhi Cheng ^c,d,e  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Axonal regeneration; Myelin associated glycoprotein; Neurodegeneration; Nogo; Tenascin; Vaccine

Indexed keywords

ALPHA SYNUCLEIN; ANTIINFLAMMATORY AGENT; DNA VACCINE; GLATIRAMER; GLYCOPROTEIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY IN 1; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; NEUTRALIZING ANTIBODY; NOGO 66 RECEPTOR; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; PROTEIN NOGO; PROTEIN NOGO A; PROTEIN NOGO(623-640); TENASCIN; TENASCIN RECEPTOR; UNCLASSIFIED DRUG; VIRUS VACCINE;

BRAIN INJURY; CELL DAMAGE; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; IMMUNE RESPONSE; INFLAMMATION; NERVE CELL; NERVE FIBER; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROGLIA; OLIGOPHRENIA; PARKINSON DISEASE; REVIEW; SEIZURE; SPINAL CORD INJURY; STROKE; VACCINATION;

ANIMALS; BRAIN INJURIES; ENCEPHALITIS; HUMANS; MULTIPLE SCLEROSIS; MYELIN PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE DEGENERATION; OLIGODENDROGLIA; SPINAL CORD INJURIES; VACCINES;

EID: 33745202076     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04404.x     Document Type: Review

References (65)

1. Raineteau O, Schwab ME. Plasticity of motor systems after incomplete spinal cord injury. Nat. Rev. Neurosci. 2001 2 : 263 73.
2. David S, Aguayo AJ. Axonal elongation into peripheral nervous system 'bridges' after central nervous system injury in adult rats. Science 1981 214 : 931 3.
3. Benfey M, Aguayo AJ. Extensive elongation of axons from rat brain into peripheral nerve grafts. Nature 1982 296 : 150 2.
4. Xu G, Nie DY, Wang WZ et al. Optic nerve regeneration in polyglycolic acid-chitosan conduits coated with recombinant L1-Fc. Neuroreport 2004 15 : 2167 72.
5. Doherty P, Williams E, Walsh FS. A soluble chimeric form of the L1 glycoprotein stimulates neurite outgrowth. Neuron 1995 14 : 57 66.
6. Chen MS, Huber AB, van der Haar ME et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigent for monoclonal antibody IN-1. Nature 2000 403 : 433 9.
7. Grandpre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 2000 403 : 439 44.
8. Prinjha R, Moore SE, Vinson M et al. Inhibitor of neurite outgrowth in humans. Nature 2000 403 : 383 4.
9. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 1994 13 : 757 67.
10. Mikol DD, Stefansson K. A phosphatidylinositol-linked peanut-bindng glycoprotein in central nervous system myelin and on oligodendrocytes. J. Cell Biol. 1988 106 : 1273 8.
11. Mikol DD, Gulcher JR, Stefansson K. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate. J. Cell Biol. 1990 110 : 471 9.
12. Pesheva P, Spiess E, Schachner M. J1-160 and J1-180 are oligodendrocyte-secreted nonpermissive substrates for cell adhesion. J. Cell Biol. 1989 109 : 1765 78.
13. Fuss B, Wintergerst ES, Bartsch U, Schachner M. Molecular characterization and in situ messenger RNA localization of the neural recognition molecule J1-160/180: A modular structure similar to tenascin. J. Cell Biol. 1993 120 : 1237 49.
14. Wintergerst ES, Fuss B, Bartsch U. Localization of janusin mRNA in the central nervous system of the developing and adult mouse. Eur. J. Neurosci. 1993 5 : 299 309.
15. Angelov DN, Walther M, Streppel M et al. Tenascin-R Is antiadhesive for activated microglia that induce down regulation of the protein after nerve injury: A new role in neuronal protection. J. Neurosci. 1998 18 : 6218 29.
16. Huber AB, Schwab ME. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. J. Biol. Chem. 2000 381 : 407 19.
17. Fournier AE, Grandpre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001 409 : 341 6.
18. Wang KC, Kim J, Srivasankaran R, Segal R, He Z. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002 420 : 74 8.
19. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite outgrowth. Neuron 1994 13 : 805 11.
20. Tang S, Woodhall RW, Shen YJ et al. Soluble myelin-associated glycoprotein (MAG) found in vivo inhibits axonal regeneration. Mol. Cell. Neurosci. 1997 9 : 333 46.
21. Vinson M, Strijbos PJLM, Rowles A et al. Myelin-associated glycoprotein interacts with ganglioside GTIb. J. Biol. Chem. 2001 276 : 280 5.
22. Liu BP, Fournier A, Grandpre T, Strittmatter SM. Myelin-associated glycoprotein is a functional ligand for the Nogo-66 receptor. Science 2002 297 : 1190 3.
23. Domeniconi M, Cao Z, Spencer T et al. Myelin-associated glycoprotein interacts with the Nogo-66 receptor to inhibit neurite outgrowth. Neuron 2002 35 : 283 90.
24. Wong ST, Henley JR, Kanning KC, Huang K, Bothwell M, Poo M. A p75NTR and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 2002 5 : 1305 8.
25. Yamashita T, Higuchi H, Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 2002 157 : 565 70.
26. Wang KC, Koprivica V, Kim JA et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 2002 417 : 941 4.
27. Kottis V, Thibault P, Mikol D et al. Oligodendrocyte-myelin glycoprotein is an inhibitor of neurite outgrowth. J. Neurochem. 2002 82 : 1566 9.
28. Pesheva P, Probstmeier R. The yin and yang of tenascin-R in central nervous system development and pathology. Prog. Neurobiol. 2000 61 : 465 93.
29. Nie DY, Zhou ZH, Ang BT et al. Nogo-A at CNS paranodes is a ligand of Caspr: Possible regulation of K(+) channel localization. EMBO J. 2003 22 : 5666 78.
30. Xiao ZC, Ragsdale DS, Malhotra JD et al. Tenascin-R is a functional modulator of sodium channel beta subunits. J. Biol. Chem. 1999 274 : 26 11 17.
31. Lotan M, Schwartz M. Cross talk between the immune system and the nervous system in response to injury: Implications for regeneration. FASEB J. 1994 8 : 1026 33.
32. Bracken MB, Shepard MJ, Holford TR et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. National acute spinal cord injury study. JAMA 1997 277 : 1597 604.
33. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 1994 6 : 712 24.
34. Liao H, Bu WY, Wang TH, Ahmed S, Xiao ZC. Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function. J. Biol. Chem. 2005 280 : 8316 23.
35. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M. Autoimmune T cells protect neurons from secondary neurodegeneration after central nervous system axotomy. Nat. Med. 1999 5 : 49 55.
36. Hauben E, Butovsky O, Nevo U et al. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 2000 20 : 6421 30.
37. Kim GM, Xu J, Xu J et al. Tumour necrosis factor receptor deletion reduces nuclear factor-kB activation, cellular inhibitor of apoptosis protein 2 expression and functional recovery after traumatic spinal cord injury. J. Neurosci. 2001 21 : 6617 25.
38. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 2001 2 : 7046 52.
39. Kipnis J, Yoles E, Schori H, Hauben E, Shaked I, Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci. 2001 21 : 4564 71.
40. Kipnis J, Mizrahi T, Yoles E, Ben-Nun A, Schwartz M. Myelin specific Th1 cells are necessary for post-traumatic protective autoimmunity. J. Neuroimmunol. 2002 130 : 78 85.
41. Popovich PG, Bucky Jones T. Manipulating the neuroinflammatory reactions in the injured spinal cord: Back to basics. Trends Pharmacol. Sci. 2003 24 : 13 17.
42. Schwartz M, Kipnis J. A common vaccine for fighting neurodegenerative disorders: Recharging immunity for homeostasis. Trends Pharmacol. Sci. 2004 25 : 407 12.
43. + regulatory T cells. Ann. N.Y. Acad. Sci. 2005 1051 : 701 8.
44. Caroni P, Schwab ME. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1988 1 : 85 96.
45. Schnell L, Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990 343 : 269 72.
46. Cadelli D, Schwab ME. Regeneration of lesioned septohippocampal acetylcholinesterase-positive axons is improved by antibodies against the myelin-associated neurite growth inhibitors NI-35-250. Eur. J. Neurosci. 1991 3 : 825 32.
47. Weibel D, Cadelli D, Schwab ME. Regeneration of lesioned rat optic nerve fibres is improved after neutralization of myelin-associated neurite growth inhibitors. Brain Res. 1994 642 : 259 66.
48. Raineteau O, Z'Graggen WJ, Thallmair M, Schwab ME. Sprouting and regeneration after pyramidotomy and blockade of the myelin-associated neurite growth inhibitors NI 3 5/250 in adult rats. Eur. J. Neurosci. 1999 11 : 1486 90.
49. Papadopoulos CM, Tsai SY, Alsbiei T, O'Brien TE, Schwab ME, Kartje GL. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann. Neurol. 2002 51 : 433 41.
50. Huang DW, McKerracher L, Braun PE, David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 1999 24 : 639 47.
51. Sicotte M, Tsatas O, Suh YJ, Cai CQ, He Z, David S. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord. Mol. Cell. Neurosci. 2003 23 : 251 63.
52. Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann. Neurol. 1990 27 : 12 17.
53. Rodriguez M, Lennon VA, Benveniste EN, Merill JE. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J. Neuropathol. Exp. Neurol. 1987 46 : 84 95.
54. Xu G, Nie DY, Chen JT et al. Recombinant DNA vaccine encoding multipledomains related to inhibitionof neurite outgrowth: A potential strategy for axonal regeneration. J. Neurochem. 2004 91 : 1018 23.
55. Hauben E, Ibarra A, Mizrahi T, Barouch R, Agranov E, Schwartz M. Vaccination with a Nogo-A-derived peptide after incomplete spinal cord injury promotes recovery via a T-cell mediated neuroprotective response: Comparison with other myelin antigens. Proc. Natl Acad. Sci. USA 2001 98 : 15 73 8.
56. Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: Relationship to neurologic disability. Curr. Opin. Neurol. 1999 12 : 295 302.
57. Karnezis T, Mandemakers W, Mcqualter JL et al. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 2004 7 : 736 44.
58. During MJ, Symes CW, Lawlor PA et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000 287 : 1453 60.
59. Masliah E, Rockenstein E, Adame A et al. Effects of α-synuclein immunization in a mouse model of Parkinson's disease. Neuron 2005 46 : 857 68.
60. Kipnis J, Nevo U, Panikashvili D et al. Therapeutic vaccination for closed head injury. J. Neurotrauma 2003 20 : 559 69.
61. Angelov DN, Waibel S, Guntinas-Lichius O et al. Therapeutic vaccine for acute and chronic motor neuron diseases: Implications for amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 2003 100 : 4790 5.
62. Schwartz M. Neurodegeneration and neuroprotection in glaucoma: Development of a therapeutic neuroprotective vaccine. The Friedenwald lecture. Invest. Ophthamol. Vis. Sci. 2003 44 : 1407 11.
63. + T cells. Eur. J. Immunol. 2004 34 : 3434 45.
64. Benner EJ, Lee Mosley R, Destache CJ et al. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA 2004 25 : 9435 40.
65. Kipnis J, Schwartz M. Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders. Trends Mol. Med. 2002 8 : 319 23.